4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0000905148-21-000282
Chief Business Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Korbel Gregory Alan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-10 | Grant or award : show line 1 in the form | +15,000 | 25,500 | D |
Loading xslF345X03/form4.xml…